Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Disponibilité géographique
4 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
82.6 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CABINET DU DR JEAN-FRANCOIS AUPY
SOS MEDECINS 95 21 RUE DES FRERES CAPUCINS, 95310 ST OUEN L AUMONE
CABINET DU DR JEAN-FRANCOIS AUPY
SOS MEDECINS 95 54 RUE VIGNERONDE, 95100 ARGENTEUIL
CABINET DU DR JEAN-FRANCOIS AUPY
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
SOS MEDECINS 95 5 RUE DES OUCHES, 95410 GROSLAY
CABINET DU DR JEAN-FRANCOIS AUPY
SOS MEDECINS 95 2 PLACE DES 7 FONTAINES, 95150 TAVERNY
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
European journal of neurology · 2014
Background and purposeAnti‐β2‐glycoprotein I (anti‐β2‐GPI) antibodies are part of the heterogeneous family of antiphospholipid antibodies and seem to be present in various neurological manifestations in addition to antiphospholipid syndrome (APS). Our objective was to analyse the clinical, radiological and therapeutic characteristics of neurological patients with positive anti‐β2‐GPI antibodies and without the Sapporo criteria for APS.MethodsThe medical records were retrospectively reviewed of 28 consecutive patients hospitalized in the Neurology Department of Strasbourg University Hospital, France, in whom anti‐β2‐GPI antibodies (immunoglobulin G and/or immunoglobulin M) were positive and other antiphospholipid antibodies negative, from November 2005 to July 2011. Clinical, radiological, biological and therapeutic data and clinical course were studied.ResultsPositive anti‐β2‐GPI antibodies were present in 28 patients. The predominant physiopathological process was mainly inflammatory (25% with myelitis, 14.3% with optic neuritis) or vascular (14.3% with cerebral ischaemia, 7.1% with cerebral vasculitis). Brain magnetic resonance imaging was performed in 89.3% of patients: atypical lesions were observed in 44% and typical inflammatory and vascular lesions in 16% and 12%, respectively.ConclusionThe anti‐β2‐GPI antibody seems to be involved in two types of neurological disease: vascular or inflammatory ‘multiple sclerosis‐like’ disease. These two types of patients frequently develop an autoimmune disease (multiple sclerosis, systemic lupus erythematosus, APS). However, a large proportion of the patients had an undefined profile with aspecific cerebral lesions and required monitoring. This study raises questions about a separate entity at the border between APS and multiple sclerosis which remains to be better defined in a larger cohort.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
European journal of neurology · 2014 · Journal Article
Renaud M, Aupy J, Uring-Lambert B, Chanson JB, et al.